Literature DB >> 7591506

Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease.

R Mielke1, J Kessler, G Fink, K Herholz, W D Heiss.   

Abstract

The relation between visual impairment and regional cerebral metabolic rate of glucose (rCMRGl) was studied in 31 patients with probable Alzheimer's disease (AD) by using positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose. To exclude any precortical cause of visual dysfunction only patients were included who had amplitudes and latencies of visually evoked potentials (flash and pattern reversal) within the normal range. Visual information processing was evaluated psychometrically by a fragmented picture test (FPT), which is a combined perception (identification score) and memory (reidentification score) task and refers to Gollin's incomplete pictures. The identification and reidentification scores were significantly worse than in normals. Reductions of the rCMRGl in the primary visual fields, and in the secondary visual fields were found. A significant partial correlation with adjustment for age between the reidentification score of the FPT and the rCMRGl of the secondary visual fields (r = -.39, p < .05) in AD patients was found, indicating involvement of the secondary visual cortex in the pathological changes in AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591506     DOI: 10.3109/00207459508994285

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  11 in total

1.  Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers.

Authors:  K R Thulborn; C Martin; J T Voyvodic
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

2.  Driver landmark and traffic sign identification in early Alzheimer's disease.

Authors:  E Y Uc; M Rizzo; S W Anderson; Q Shi; J D Dawson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

3.  The picture superiority effect in patients with Alzheimer's disease and mild cognitive impairment.

Authors:  Brandon A Ally; Carl A Gold; Andrew E Budson
Journal:  Neuropsychologia       Date:  2008-10-17       Impact factor: 3.139

Review 4.  Prosaccade and Antisaccade Paradigms in Persons with Alzheimer's Disease: A Meta-Analytic Review.

Authors:  Naomi Kahana Levy; Michal Lavidor; Eli Vakil
Journal:  Neuropsychol Rev       Date:  2017-10-27       Impact factor: 7.444

5.  Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints.

Authors:  Shannon L Risacher; Darrell Wudunn; Susan M Pepin; Tamiko R MaGee; Brenna C McDonald; Laura A Flashman; Heather A Wishart; Heather S Pixley; Laura A Rabin; Nadia Paré; Jessica J Englert; Eben Schwartz; Joshua R Curtain; John D West; Darren P O'Neill; Robert B Santulli; Richard W Newman; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2012-10-18       Impact factor: 4.673

Review 6.  Prospects for prediction: ethics analysis of neuroimaging in Alzheimer's disease.

Authors:  J Illes; A Rosen; M Greicius; E Racine
Journal:  Ann N Y Acad Sci       Date:  2007-02       Impact factor: 5.691

7.  Ocular manifestations of Alzheimer's disease in animal models.

Authors:  Miles Parnell; Li Guo; Mohamed Abdi; M Francesca Cordeiro
Journal:  Int J Alzheimers Dis       Date:  2012-05-15

8.  Eyetracking Metrics in Young Onset Alzheimer's Disease: A Window into Cognitive Visual Functions.

Authors:  Ivanna M Pavisic; Nicholas C Firth; Samuel Parsons; David Martinez Rego; Timothy J Shakespeare; Keir X X Yong; Catherine F Slattery; Ross W Paterson; Alexander J M Foulkes; Kirsty Macpherson; Amelia M Carton; Daniel C Alexander; John Shawe-Taylor; Nick C Fox; Jonathan M Schott; Sebastian J Crutch; Silvia Primativo
Journal:  Front Neurol       Date:  2017-08-07       Impact factor: 4.003

9.  Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.

Authors:  S Frost; Y Kanagasingam; H Sohrabi; J Vignarajan; P Bourgeat; O Salvado; V Villemagne; C C Rowe; S Lance Macaulay; C Szoeke; K A Ellis; D Ames; C L Masters; S Rainey-Smith; R N Martins
Journal:  Transl Psychiatry       Date:  2013-02-26       Impact factor: 6.222

10.  The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.

Authors:  Anna Sandebring; Hedvig Welander; Bengt Winblad; Caroline Graff; Lars O Tjernberg
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.